Dr Norman Swan

Dr Norman Swan has been Australia’s top health and medical science broadcaster for the last four decades, producing and delivering radio and TV programs across all areas. He is nationally and internationally recognised as an outstanding communicator to educate the public about the latest research in health, disease, treatments and research. Dr Swan has championed […]

Professor Sophia Zoungas

Professor Sophia Zoungas, Head of the School of Public Health and Preventive Medicine at Monash University, is a Clinical Endocrinologist recognised internationally for her role in advancing knowledge in the management of diabetes and its vascular complications. She leads Australia’s largest translational research program in diabetes care and benchmarking of diabetes services. Professor Zounga’s research […]

Professor Di Yu

Professor Di Yu is an immunologist, global highly cited researcher, and NHMRC Leadership Fellow. He is internationally recognised for the discovery of novel T lymphocyte subsets and their molecular regulators, relevant to health and disease. Bridging the gap between basic immunology and translation, Professor Yu actively collaborates with clinicians and has initiated clinical studies and […]

Distinguished Professor Patsy Yates

Distinguished Professor Patsy Yates is over 20 years post-PhD and is a leading authority in palliative care services research. She has significant original contributions that have had a positive impact on health and medical research, the health system, economy and/or the health of the population, particularly in cancer and palliative care services. Distinguished Professor Yates […]

Professor Bruce Taylor

Professor Bruce Taylor is a clinician-scientist who leads a large and diverse research group, undertaking internationally significant research in the field of neuroscience. He is also a senior consultant neurologist with a special interest in multiple sclerosis (MS). Professor Taylor’s research focuses on the personal, environmental and genetic factors associated with the onset and progression […]

Professor Mark Stevenson

Professor Mark Stevenson is an internationally renowned epidemiologist whose research and advocacy have led to transport and public health policies that have reduced the global burden of injury. His landmark research associated with mobile phone use and the risk of car crash led to legislative change across five countries. Additionally, his research on young driver […]

Professor Ben Solomon

Professor Ben Solomon is a clinician-scientist whose clinical and translational research has identified new treatments, changed standards of care and improved outcomes for patients with lung cancer, the leading cause of cancer-related death. His work has resulted in regulatory approvals for first, second and third generation ALK TKIs, defining new and transformative standards of care […]

Professor Jason Roberts

Professor Jason Roberts has been instrumental in guiding evidence-based dosing of antimicrobials in critically ill patients with serious infections. This work has been recognised internationally for its global impact and he is the most published author in this field worldwide, as his findings form the basis of numerous therapeutic guidelines. Professor Roberts has a substantial […]

Professor Shanthakumar Rajaratnam

Professor Shantha Rajaratnam’s research has taken circadian neuroscience into new clinical approaches: melatonin agonist (to FDA approval), light therapy and digital applications. He has published more than 165 peer-reviewed papers and two edited books, and he has led the peak body for sleep health and medicine (Australasian Sleep Association). He currently leads the Sleep Health […]

Professor Anna Nowak

Professor Anna Nowak is a medical oncologist, clinical triallist and tumour immunology researcher with a focus on the cancer mesothelioma. She developed the first measurement criteria specific to the unique growth pattern of mesothelioma, which are used in clinical trials worldwide. Professor Nowak was an early investigator of chemo-immunotherapy combinations in the laboratory, advancing our […]

Professor Eric Morand

Professor Eric Morand is an internationally renowned academic physician-scientist. His career has focused on integrating clinical and laboratory science to advance patient outcomes in lupus. Professor Morand founded a multinational consortium to design and validate new clinical endpoints, solving a decade-long impasse responsible for multiple failed trials. He led the breakthrough Phase 3 trial of […]

Professor Laura Mackay

Professor Laura Mackay is a Howard Hughes and Bill and Melinda Gates-funded International Scholar, Sylvia and Charles Viertel Senior Research Fellow, NHMRC Leadership Fellow and Dame Kate Campbell Fellow. She has is an internationally recognised expert in T cell immunity, contributing landmark papers that have defined how memory T cell responses are generated in body […]

Professor Kristine Macartney

Professor Kristine Macartney is a vaccinologist, infectious diseases paediatrician and Director of the National Centre for Immunisation Research and Surveillance (NCIRS). She is an expert on vaccine safety, policy and implementation, and vaccine preventable viral diseases, including influenza, SARS-CoV-2 (cause of COVID-19), rotavirus and varicella-zoster. Professor Macartney is a member of WHO advisory groups, including […]

Professor Emma Kowal

Professor Emma Kowal is a leading expert in the social, ethical and cultural implications of genomics in Aboriginal and Torres Strait Islander communities. As a result of her research, Indigenous genomics has developed as a recognised area of importance both within Indigenous health and within precision medicine. Professor Kowal’s work developing national frameworks for biospecimen […]

Professor Anne Kavanagh

Professor Anne Kavanagh is an epidemiologist and public health physician who has made substantial contributions to knowledge across three areas: cancer screening, health inequities and disability. Her research has had major impacts on policy, including in relation to mammographic screening, local government priorities to promote healthy behaviour and approaches to improving the health of people […]

Professor Carol Hodgson

Professor Carol Hodgson has an exceptional track record and leads a multidisciplinary, international research program in functional recovery after critical illness. This program has changed clinical practice and contributed new knowledge in the field, including international guidelines. Professor Hodgson is ranked in the top 1% worldwide for her expertise in topics such as ‘Critical Care’, […]

Professor Jane Hocking

Professor Jane Hocking is an epidemiologist, whose research on chlamydia has led to paradigm changes in policy, with changed treatment guidelines globally. She has demonstrated excellence through multiple plenary and symposia presentations at international conferences and membership on national and international committees informing policy. She has published over 375 peer-reviewed papers, with publications on NEJM […]

Professor Sarah Hilmer

Professor Sarah Hilmer is nationally and internationally recognised for excellence in geriatric pharmacology. She has made significant, sustained contributions to the field since her PhD was awarded in 2005, with over 300 publications and 10,000 citations, and national and international collaborations. She has chaired institutional, state and international committees aiming to advance clinical pharmacology and […]

Professor Sharon Friel

Professor Sharon Friel is a world–renowned policy-focused health equity researcher. She is an ARC Laureate Fellow since 2021 and Director of Menzies Centre for Health Governance, Australian National University. Professor Friel was Head of the Scientific Secretariat (University College London) for the World Health Organisation Commission on Social Determinants of Health. She has published widely […]

Professor Michael Friedlander

Professor Michael Friedlander has an extensive track record of research into gynaecological and breast malignancies, with major focus on innovative clinical trials in ovarian cancer and using patient reported outcomes as endpoints in clinical trials. His extensively cited and influential work has led to important, lasting changes in clinical cancer treatment and improved patient outcomes. […]